Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
about
Pathophysiology of thrombotic thrombocytopenic purpuraCurrent concepts in thrombotic thrombocytopenic purpuraPathogenesis of thrombotic microangiopathiesBench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivistIs severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? YesSubacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpuraPernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the LiteratureRole of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Ticlopidine-Associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity.Ticlopidine-induced thrombotic thrombocytopenic purpura: two case reports treated with plasma exchange plus steroids.A new name in thrombosis, ADAMTS13.Acute thrombotic thrombocytopenic purpura following orthopedic surgery.Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades.Thrombotic thrombocytopenic purpura associated with abacavir in a patient with HIV infection.Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review.A journey from sickle cell anemia to ADAMTS13.Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center.Autoimmune thrombocytopenias.Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS.A case of mixed connective tissue disease complicated with thrombotic thrombocytopenic purpura.Treatment of thrombotic thrombocytopenic purpura.ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.Thrombotic thrombocytopenic purpura: survival by "giving a dam"Journey in reverse: TTP from bedside to blood bank to bench.ADAMTS13 and microvascular thrombosisPathogenesis and prognosis of thrombotic microangiopathy.Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiencyTwo mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.The thrombotic microangiopathies.The kidney in thrombotic thrombocytopenic purpura.Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.Thrombotic microangiopathies: multimers, metalloprotease, and beyond.
P2860
Q24614117-B2822D84-8F97-4E41-BD3A-864B6849F21AQ24656680-60B0B228-8359-4DA9-9520-1BF5FF7E196DQ24658043-DB5CE76F-88D1-4B82-A544-2D6D9C879215Q27485164-411FE5BB-2A0F-4B66-8193-79DFFD76DC8CQ28188189-2CBBEAD6-565B-4A3B-BE68-74C07DF47105Q28213393-6F22185D-FD33-48DB-9E0F-8C42F084533EQ33168354-C5D89EEB-1AEF-43B0-84D1-38F9ACAF4FB2Q33337854-C6965CE2-033D-47B2-9515-23DB0A97E39AQ33339170-9588FFC0-CFE0-4C78-A5F8-E36FC8D27384Q33339749-E9827B1C-F803-48FE-A99B-4DBB7E1BC48BQ33339949-9EF3B045-F580-4FF6-9588-8A85023CFC33Q33340481-ECE3191E-E9E0-4F59-8EB9-A29971825F39Q33343892-B005E6FF-9586-486F-90C9-9D4B3AD8AAA4Q33344699-088EE9B5-8780-44B1-9F70-DDCA947C1009Q33345282-283B98EB-0FC0-4B60-870C-4447FC1777B2Q33346559-B16EEC91-0528-4EBB-A68F-898A78A20BE0Q33358266-2810BC41-3683-4722-A08E-343FE73138D4Q33359746-B47F4BE1-F5AA-4D96-AEE8-639D81028A41Q33361713-1D179673-17AB-4CF2-B8B5-E26FA0FDF166Q33362294-6AF9B697-18DB-4FFD-8E1E-5152AE2001E8Q33363304-E984E1EF-843B-43CC-9F47-1ED40113C92EQ33363539-8136E540-801A-45A8-9E5D-15632F35C6C0Q33369048-F2939BF4-7DE7-40E9-995C-BBFF4326ABAAQ33369798-3FEF2D3B-2B90-4145-8FEA-B277B45181C1Q33370956-704A05B1-2FD5-4BD2-898C-256999C603F8Q33371103-7728CCE8-AFDA-4707-B27B-F1EF7AFC23DBQ33372115-B7A80F4C-186A-4213-A218-7427FC0BAE6AQ33373067-AD150367-3307-488C-A5F0-1EB0AEFE6D2FQ33373368-C293587F-AE90-4DCA-9E32-C6963E9AF68BQ33373608-E4B3AC46-B1F8-4B7B-8667-891A9159B19FQ33375692-A24C5662-83FE-4414-AAE7-9F4C46235543Q33376071-AA19A336-646B-44F3-AF7C-60C81D1DA0BBQ33376683-0A8A4167-CCCC-4EA0-99DC-B851757023C0Q33376858-305A3047-A4A7-4B49-BA11-9D398990D878Q33378755-0BCE06A6-BB4A-4E2A-BCDC-6BEDBE3AC1CFQ33381242-4A3FC229-9598-4F4F-A18C-128DC857AB46Q33382999-63E50E0F-6871-44C0-877D-34A6FEEB5931Q33383006-DE0DBE17-572B-4F5E-86BD-4E3EEDC0096EQ33383355-87932EE7-6D90-41A0-8A33-8A007CD6FAE8Q33389435-2927FF92-CF93-4B40-A846-C1025804C009
P2860
Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@ast
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@en
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@nl
type
label
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@ast
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@en
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@nl
prefLabel
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@ast
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@en
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@nl
P2093
P2860
P1476
Antibody inhibitors to von Wil ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P304
P356
10.7326/0003-4819-132-10-200005160-00005
P407
P577
2000-05-01T00:00:00Z